Trials / Completed
CompletedNCT00328939
ARIXTRA Local Study For Registration In China.
Randomized, Single Blind, Parallel Study to Compare the Safety and Efficacy of ARIXTRA to Enoxaparine in Patients Undergoing Elective Major Hip or Knee Replacement or a Revision of Components.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 240 (planned)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a local registration study in China to compare the safety and efficacy of ARIXTRA to Enoxaparine in patients undergoing elective major hip or knee replacement or a revision of components.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ARIXTRA infusion | |
| DRUG | Enoxaparine infusion |
Timeline
- Start date
- 2004-05-01
- First posted
- 2006-05-24
- Last updated
- 2012-06-04
Locations
7 sites across 1 country: China
Source: ClinicalTrials.gov record NCT00328939. Inclusion in this directory is not an endorsement.